Published in Toxicol Sci on November 10, 2006
Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect (2007) 3.03
Endocrine disrupters as obesogens. Mol Cell Endocrinol (2009) 2.80
Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect (2008) 1.52
Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ Health Perspect (2011) 1.37
Minireview: the case for obesogens. Mol Endocrinol (2009) 1.33
Childhood obesity and environmental chemicals. Mt Sinai J Med (2011) 1.31
Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice. Toxicol Sci (2010) 1.23
Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ Health Perspect (2012) 1.21
The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol (2008) 1.17
The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ Health Perspect (2014) 1.13
Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod Toxicol (2008) 1.11
Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod Toxicol (2008) 1.09
Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect (2008) 1.03
Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. Reprod Toxicol (2009) 0.99
Peroxisome proliferator-activated receptors alpha, Beta, and gamma mRNA and protein expression in human fetal tissues. PPAR Res (2010) 0.92
The epigenetic lorax: gene-environment interactions in human health. Epigenomics (2012) 0.92
Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort. Environ Int (2010) 0.89
Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice. Reprod Toxicol (2012) 0.88
Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha. PPAR Res (2010) 0.84
Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups. Reprod Toxicol (2008) 0.82
Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required. Toxicol Pathol (2014) 0.78
Programming of metabolic effects in C57BL/6JxFVB mice by in utero and lactational exposure to perfluorooctanoic acid. Arch Toxicol (2015) 0.76
Metabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated Receptors. PLoS One (2015) 0.76
Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect (2005) 7.43
Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection. Sci Transl Med (2010) 5.85
Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect (2004) 5.32
Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect (2005) 4.93
Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect (2004) 4.50
Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem (2005) 4.01
Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect (2007) 3.87
Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect (2007) 3.33
Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect (2008) 3.13
Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect (2008) 3.11
Baby care products: possible sources of infant phthalate exposure. Pediatrics (2008) 2.97
Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). Environ Sci Technol (2007) 2.88
Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect (2010) 2.83
Quantification of 22 phthalate metabolites in human urine. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 2.80
Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect (2011) 2.79
Temporal trends in phthalate exposures: findings from the National Health and Nutrition Examination Survey, 2001-2010. Environ Health Perspect (2014) 2.78
Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect (2008) 2.75
Polycarbonate bottle use and urinary bisphenol A concentrations. Environ Health Perspect (2009) 2.72
Prenatal bisphenol A exposure and early childhood behavior. Environ Health Perspect (2009) 2.67
Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology (2006) 2.63
Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci (2009) 2.58
Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. Anal Chem (2005) 2.52
Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics (2011) 2.44
Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci (2011) 2.43
Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect (2012) 2.43
Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ Sci Technol (2011) 2.40
Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect (2003) 2.27
Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid. Epidemiology (2013) 2.13
Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect (2011) 2.13
Exposure to bisphenol A from bis-glycidyl dimethacrylate-based dental sealants. J Am Dent Assoc (2006) 2.13
Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect (2005) 2.12
Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect (2010) 2.08
Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect (2007) 2.04
Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol (2006) 1.98
Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem (2005) 1.98
Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environ Health Perspect (2012) 1.96
Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect (2007) 1.92
Analysis of human urine for fifteen phthalate metabolites using automated solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.91
Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect (2013) 1.89
Medications as a source of human exposure to phthalates. Environ Health Perspect (2004) 1.84
Prenatal phthalate exposure and performance on the Neonatal Behavioral Assessment Scale in a multiethnic birth cohort. Neurotoxicology (2009) 1.83
Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem (2005) 1.80
Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ Health Perspect (2003) 1.79
Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ Health Perspect (2011) 1.79
Urinary biomarkers for phthalates associated with asthma in Norwegian children. Environ Health Perspect (2012) 1.74
Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ Sci Technol (2013) 1.71
Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ Health Perspect (2011) 1.71
Endocrine disruptors and childhood social impairment. Neurotoxicology (2010) 1.71
Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ Health Perspect (2013) 1.71
Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect (2010) 1.68
Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Perspect (2010) 1.67
Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci (2006) 1.65
Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch Toxicol (2003) 1.62
Urinary metabolites of di(2-ethylhexyl) phthalate are associated with decreased steroid hormone levels in adult men. J Androl (2008) 1.62
Phthalate diesters and their metabolites in human breast milk, blood or serum, and urine as biomarkers of exposure in vulnerable populations. Environ Health Perspect (2008) 1.61
Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol (2007) 1.59
Urinary phthalate metabolites in relation to preterm birth in Mexico city. Environ Health Perspect (2009) 1.59
Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. J Virol (2011) 1.56
Personal care product use and urinary levels of phthalate metabolites in Mexican women. Environ Int (2011) 1.56
Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol (2009) 1.56
Phthalate exposure and reproductive hormones in adult men. Hum Reprod (2004) 1.52
Prenatal bisphenol a exposure and child behavior in an inner-city cohort. Environ Health Perspect (2012) 1.50
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod (2012) 1.48
Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001-2002. Environ Sci Technol (2009) 1.48
Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. Toxicol Sci (2007) 1.48
Maternal urinary metabolites of Di-(2-Ethylhexyl) phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study. Am J Epidemiol (2009) 1.47
Canned soup consumption and urinary bisphenol A: a randomized crossover trial. JAMA (2011) 1.47
Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ Health Perspect (2004) 1.45
Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect (2008) 1.45
Semen quality and sperm DNA damage in relation to urinary bisphenol A among men from an infertility clinic. Reprod Toxicol (2010) 1.45
Quantification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.45
Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation. Environ Health Perspect (2015) 1.44
Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol (2004) 1.44
Bisphenol a exposure in Mexico City and risk of prematurity: a pilot nested case control study. Environ Health (2010) 1.42
Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age. Environ Health Perspect (2011) 1.42
A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. Toxicol Sci (2004) 1.41
Urinary and air phthalate concentrations and self-reported use of personal care products among minority pregnant women in New York city. J Expo Sci Environ Epidemiol (2010) 1.39
Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci (2006) 1.38
Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ Health Perspect (2011) 1.37
Urinary bisphenol A concentrations in relation to serum thyroid and reproductive hormone levels in men from an infertility clinic. Environ Sci Technol (2010) 1.37
Urinary concentrations of phthalates and phenols in a population of Spanish pregnant women and children. Environ Int (2011) 1.36
Endocrine disrupting properties of perfluorooctanoic acid. J Steroid Biochem Mol Biol (2011) 1.36
Prenatal exposure to bisphenol A and phthalates and infant neurobehavior. Neurotoxicol Teratol (2011) 1.34
Parabens as urinary biomarkers of exposure in humans. Environ Health Perspect (2006) 1.34
Prenatal di(2-ethylhexyl)phthalate exposure and length of gestation among an inner-city cohort. Pediatrics (2009) 1.34
Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect (2012) 1.34
Temporal stability of the conjugated species of bisphenol A, parabens, and other environmental phenols in human urine. J Expo Sci Environ Epidemiol (2007) 1.32
Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance. Environ Health Perspect (2006) 1.32
Exposure to phthalates and breast cancer risk in northern Mexico. Environ Health Perspect (2010) 1.30
Intra- and inter-individual variability of urinary phthalate metabolite concentrations in Hmong women of reproductive age. J Expo Sci Environ Epidemiol (2009) 1.30